Primary trigeminal afferents are the main source for stimulus-induced CGRP release into jugular vein blood and CSF

BI 44370 TA, an oral CGRP antagonist for the treatment of acute migraine attacks: Results from a phase II study

(2010) Hans-Christoph Diener et al.   CEPHALALGIA

CGRP and its receptors provide new insights into migraine pathophysiology

(2010) Tony W. Ho et al.   Nature Reviews Neurology

Role for voltage gated calcium channels in calcitonin gene-related peptide release in the rat trigeminovascular system

(2010) D.V. Amrutkar et al.   NEUROSCIENCE

Possible sites of action of the new calcitonin gene-related peptide receptor antagonists

(2010) Sajedeh Eftekhari et al.   Therapeutic Advances in Neurological Disorders

Intracisternal Injection of Inflammatory Soup Activates the Trigeminal Nerve System

(2009) J Hoffmann et al.   CEPHALALGIA

The role of CGRP in the pathophysiology of migraine and efficacy of CGRP receptor antagonists as acute antimigraine drugs

(2009) Carlos M. Villalón et al.   PHARMACOLOGY & THERAPEUTICS

The effect of neonatal capsaicin treatment on the CGRP-immunoreaction in the trigeminal subnucleus caudalis of mice

(2008) Megumi AITA et al.   BIOMEDICAL RESEARCH-TOKYO

Almotriptan and Its Combination with Aceclofenac For Migraine Attacks: A Study of Efficacy and The Influence of Auto-Evaluated Brush Allodynia

(2008) J Schoenen et al.   CEPHALALGIA

Early vs. Non-Early Intervention in Acute Migraine — ‘Act When Mild (AwM)’. A Double-Blind, Placebo-Controlled Trial of Almotriptan

(2008) PJ Goadsby et al.   CEPHALALGIA

Efficacy and tolerability of MK-0974 (telcagepant), a new oral antagonist of calcitonin gene-related peptide receptor, compared with zolmitriptan for acute migraine: a randomised, placebo-controlled, parallel-treatment trial

(2008) Tony W Ho et al.   LANCET